149. Hemiconvulsion hemiplegia epilepsy syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 25 / Drugs : 35 - (DrugBank : 13) / Drug target genes : 16 - Drug target pathways : 22
Hemiconvulsion hemiplegia epilepsy syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
149 | Hemiconvulsion hemiplegia epilepsy syndrome |
2 | Amyotrophic lateral sclerosis |
13 | Multiple sclerosis/Neuromyelitis optica |
6 | Parkinson disease |
144 | Lennox-Gastaut syndrome |
8 | Huntington disease |
145 | West syndrome |
127 | Frontotemporal lobar degeneration |
140 | Dorabe syndrome |
86 | Pulmonary arterial hypertension |
10 | Charcot-Marie-Tooth disease |
256 | Muscle glycogenosis |
58 | Hypertrophic cardiomyopathy |
90 | Retinitis pigmentosa |
34 | Neurofibromatosis |
65 | Primary immunodeficiency |
97 | Ulcerative colitis |
102 | Rubinstein-Taybi syndrome |
46 | Malignant rheumatoid arthritis |
233 | Wolfram syndrome |
206 | Fragile X syndrome |
226 | Interstitial cystitis with Hunners ulcer |
5 | Progressive supranuclear palsy |
202 | Smith-Magenis syndrome |
156 | Rett syndrome |
85 | Idiopathic interstitial pneumonia |